Psychological impact of screening and prediction in type 1 diabetes

Current Diabetes Reports

Volumn 11, Issue 5, 2011, Pages 454-459

  Johnson, Suzanne Bennett ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Behavior; Emotions; Psychological; Risk perceptions; Screening; Type 1 diabetes

Indexed keywords

ANXIETY; ARTICLE; BEHAVIOR; COGNITION; DEPRESSION; EMOTION; GENETIC ANALYSIS; GENOTYPE; HLA SYSTEM; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INTERNAL VALIDITY; PREDICTION; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SCREENING;

EID: 80755133726     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0208-9     Document Type: Article

References (49)

1. Schatz D, Krischer J, She JX. To screen or not to screen for pretype 1 diabetes? Horm Res. 2002;57 suppl 1:12-7.
2. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002;346:1685-91.
3. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of oral insulin in relatives of patients with type 1 diabetes mellitus. Diabetes Care. 2005;28:1068-76.
4. Gale EA, Bingley PJ, Emmett CL, Collier T, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet. 2004;363:925-31.
5. TRIGR Study Group, Akerblom HK, Krischer J, Virtanen SM, Berseth C, Becker D, et al. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia. 2011;54:627-33.
6. TEDDY Study Group. The Environmental Determinants in the Young (TEDDY) study: Study design. Pediatr Diabetes. 2007;8:286-98.
7. Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41:11-8.
8. Galesic M, Garcia-Retamero R. Communicating consequences of risky behaviors: life expectancy versus risk of disease. Patient Educ Couns. 2011;82:30-5.
9. Almond B. Genetic profiling of newborns: ethical and social issues. Genetics. 2006;7:67-71. (Pubitemid 41828949)
10. Ross L. Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med. 2003;157:89-95. (Pubitemid 36347803)
11. American Academy of Pediatrics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107:1451-5.
12. Roth R. Psychological and ethical aspects of prevention trials. J Pediatr Endocrinol Metab. 2001;14:669-74. (Pubitemid 32479519)
13. Johnson SB. Screening programs to identify children at risk for diabetes mellitus: Psychological impact on children and parents. J Pediatr Endocrinol Metab. 2001;14:653-60.
14. Rewers M, Bugawan T, Norris J, Blair A, Beaty B, Hoffman M, et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 1996;39:807-12. (Pubitemid 26228110)
15. Wion E, Brantley M, Stevens J, Gallinger S, Peng H, Glass M, et al. Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann N YAcad Sci. 2003;1005:400-3. (Pubitemid 38507794)
16. Hoppu S, Ronkainen M, Kimpimäki T, Erkkilä S, Korhonen S, Ilonen J, et al. Insulin autoantibody isotypes during the prediabetic process in children with increased genetic risk for type1 diabetes: The Finnish Type 1 Diabetes Prediction and Prevention Study. Pediatr Res. 2004;54:236-42. (Pubitemid 38121001)
17. Hummel M, Ziegler A, Roth R. Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med. 2004;21:324-8. (Pubitemid 38519666)
18. Stolt UG, Helgesson G, Liss P-E, Svensson T, Ludviggson J. Information and informed consent in a longitudinal screening involving children: a questionnaire survey. Eur J Hum Genet. 2005;13:376-83. (Pubitemid 40360794)
19. Lernmark B, Elding-Larsson H, Hansson G, Lindberg B, Lynch K, Sjoblad S. Parent responses to participation in genetic screening for diabetes risk. Pediatr Diabetes. 2004;5:174-81. (Pubitemid 40057686)
20. Kerruish N. Parents' experiences of newborn screening for genetically susceptibility to type 1 diabetes. J Med Ethics. 2011;37:348-53.
21. Aas KK, Tambs K, Kise MS, Magnus P, Ronningen KS: Genetic testing of newborns for type 1 susceptibility: a prospective cohort study on effects on maternal mental health. BMC Medical Genetics 2010;11:112. Surveys conducted when the child was 6 months of age found no mental health differences between mothers of children identified as genetically at risk for T1D at birth and mothers of newborns without genetic risk . However, mothers who had T1D themselves reported greater worry.
22. Lernmark B, Johnson SB, Vehik K, Smith L, Ballard L, Baxter J, McLeod W, Roth R, Simell T on behalf of the TEDDY Study Group: Enrollment Experiences in a Pediatric Longitudinal Observational Study: The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Contemporary Clinical Trials 2011, in press.
23. Johnson SB. Type 1 diabetes risk. In: Tercyak KP, editor. Handbook of genomics and the family: issues in clinical child psychology. New York: Springer; 2010. p. 293-310.
24. Hendrieckx C, De Smer F, Kristoffersen I, Bradley C. Risk assessment for developing type 1 diabetes: intentions of behavioural changes prior to risk notification. Diabetes Metab Res Rev. 2002;18:36-42. (Pubitemid 34257364)
25. Johnson SB, Lee H-S, Baxter J, Lernmark B, Roth R, Simmell T for the TEDDY Study Group: The Environmental Determinants of Diabetes in the Young TEDDY) Study: predictors of early study withdrawal among participants with no family history of type 1 diabetes. Pediatric Diabetes 2011;12:165-171. Mothers who underestimated their child's risk for T1D at study inception were more likely to leave the study during the first year compared to mothers with accurate risk perceptions. In addition, high anxiety among mothers with accurate risk perceptions was associated with early study withdrawal.
26. Carmichael SK, Johnson SB, Baughcum A, North K, Hopkins D, Dukes MG, et al. Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet Med. 2003;5:77-83. (Pubitemid 36992616)
27. Hood K, Johnson SB, Baughcum A, She J, Schatz D. Maternal understanding of infant diabetes risk: differential effects of maternal anxiety and depression. Genet Med. 2006;8:665-70. (Pubitemid 44674002)
28. Johnson SB. Genetic screening for type 1 diabetes: Psychosocial impact on families. In: Miller S, McDaniel S, Rolland J, Feetham S, editors. Individuals, families, and the new era of genetics. New York: Norton; 2006. p. 404-22.
29. Heshka JT, Palleschi C, Howley H, Wilson B, Wells P. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med. 2008;10:19-32.
30. Johnson SB, Baughcum A, Hood K, Rafkin-Mervis L, Schatz D for the DPT-1 Study group: (2007). Participant and parent experiences in the parenteral insulin arm of the Diabetes Prevention Trial for Type 1 Diabetes. Diabetes Care 2007;30:2193-8. (Pubitemid 47359013)
31. Johnson SB, Baughcum A, Rafkin-Mervis L, Schatz D for the DPT-1 Study group: Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes. Pediatr Diabetes 2009;30:2193-8. In this randomized trial of oral insulin to prevent T1D in at-risk children and adults, 48% of participants and 38% of parents reported engaging in behaviors outside of the trial to delay or prevent diabetes; change in diet was the most common diabetes prevention behavior reported. (Pubitemid 47359013)
32. Speilberger C. Manual for the State-Trait Anxiety Inventory STAI (Form Y) 1983. Palo Alto: Consulting Psychologists; 1983.
33. Speilberger C. Test Manual for the State-Trait Anxiety Inventory for Children 1973. Palo Alto: Consulting Psychologists; 1973.
34. Speilberger C, Gorsuch R, Lushene R: Test Manual for the State- Trait Anxiety Inventory 1970. Palo Alto, CA: Consulting Psychologists Press.
35. Johnson SB, Riley W, Hansen C, Nurick M. Psychological impact of islet cell-antibody screening: preliminary results. Diabetes Care. 1990;13:93-7. (Pubitemid 20056197)
36. Johnson SB, Tercyak K. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care. 1995;18:1370-2.
37. Johnson SB, Baughcum A, Carmichael S, She J-X, Schatz D. Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care. 2004;27:392-7. (Pubitemid 38174063)
38. Carmichael, S: Newborn Genetic Screening for Type I Diabetes: Factors Affecting Maternal Risk Perception, Anxiety and Study Participation. Doctoral Dissertation 2003, University of Florida.
39. Simonen P, Korhonen T, Simell T, Keskinenk P, Karkkainen M, Knip M, et al. Parental reactions to information about increased genetic risk of type 1 diabetes mellitus in infants. Arch Pediatr Adolesc Med. 2006;160:1131-6. (Pubitemid 44714393)
40. Kerruish N, Campbell-Stokes P, Gray A, Merriman T, Robertson S, Taylor B. Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics. 2007;120:e324-35. (Pubitemid 47219483)
41. Johnson SB, Lernmark B, Baxter J, Roth R, Simell T, Mcleod W, and the TEDDY group: At-risk for type 1 diabetes (T1D): Parent anxiety in response to newborn genetic screening results in the Environmental Determinants of Diabetes in the Young (TEDDY) Study. Diabetes 2007, 56 Supplement 1: A498.
42. Goldstein E, Hermann R, Renfors TJ, Näntö-Salonen KM, Korhonen T, Kärkkäinen M, et al. From genetic risk awareness to overt type 1 diabetes: parental stress in a placebo-controlled prevention trial. Diabetes Care. 2009;32:2181-3.
43. Hood K, Johnson SB, Carmichael S, Laffel L, She J, Schatz D. Depressive in mothers of infants identified as genetically at risk for type 1 diabetes. Diabetes Care. 2005;28:1898-903. (Pubitemid 41060960)
44. Johnson SB, Carmichael S. At-risk for diabetes: coping with the news. J Clin Psychol Med Settings. 2000;7:69-78.
45. Lucidarme N, Domingues-Muriel E, Castro D, Czernichow P, Levy-Marshall C. Appraisal and implications of predictive testing for insulin-dependent diabetes mellitus. Diabetes Metab. 1998;23:550-3. (Pubitemid 29048426)
46. Helgesson G, Swarling U. Views on data use, confidentiality and consent in a predictive screening involving children. J Med Ethics. 2008;2008(34):206-9.
47. Stolt UG, Liss P-E, Ludvigsson J, for the ABIS Study Group. Parents want to know if their child is at high risk of getting diabetes. Ann N YAcad Sci. 2003;1005:395-9. (Pubitemid 38507793)
48. Swartling U, Eriksson S, Ludvigsson J, Helgesson G. Concern, pressure and lack of knowledge affect choice of not wanting to know high-risk status. Eur J Hum Genet. 2007;2007(14):556-62. (Pubitemid 46681460)
49. Baughcum A, Johnson SB, Carmichael S, Lewin A, She J-X, Schatz D. Maternal efforts to prevent type 1 diabetes in at-risk children. Diabetes Care. 2005;28:916-21. (Pubitemid 40434495)